Results 131 to 140 of about 36,039 (270)
ABSTRACT Objective To evaluate the efficacy of prophylactic photobiomodulation therapy (PBMT) in preventing oral mucositis (OM) and to assess serum and salivary methotrexate (MTX) levels as predictors of OM in adults receiving high‐dose methotrexate (HD‐MTX).
Letícia Rodrigues‐Oliveira +21 more
wiley +1 more source
This article summarized the multidisciplinary collaboration and nursing practice of bone marrow suppression combined with catheter-related bloodstream infection (CRBSI) of implanted port in a patient undergoing chemotherapy for lung cancer.
WEI Ya (魏雅) +5 more
doaj +1 more source
OC-046 Nudt15 variants contribute to thiopurine-induced myelosuppression in european populations
OC-046 Nudt15 variants contribute to thiopurine-induced myelosuppression in european ...
PJ Hendy (19228165) +9 more
core
Toxicity of Cytarabine Intravenous Constant Rate Infusion in Cats With Lymphoma
ABSTRACT Cytarabine intravenous constant rate infusion (IV CRI) toxicity in cats with lymphoma has not been well documented. We aimed to assess toxicities following cytarabine IV CRI as a single‐agent or within a multiagent protocol in cats with lymphoma. Medical records of cats with lymphoma treated with cytarabine IV CRI, with documented dose, route,
Rachel Hanford +5 more
wiley +1 more source
ABSTRACT Background Progressive feline leukemia virus (FeLV) infection and anemia of suspected immune‐mediated origin (ASIMO) are associated with similar hematologic abnormalities, including anemia, neutropenia, and lymphocytosis. Cats with ASIMO may test positive for FeLV using point‐of‐care (POC) ELISA tests.
Nicholas Kelly +4 more
wiley +1 more source
Background: Myelosuppression is one of the most common chemotherapy side effects, seriously threatening the quality of life of cancer patients. Studies have shown that velvet antler polypeptides (VAPs) could enhance immunity and anti-aging and also have ...
Rui Du +19 more
core +1 more source
Currently, there are at least 30 ongoing clinical trials in the enrollment phase to evaluate adding concurrent ICIs to the PACIFIC regimen for a variety of solid tumors. Considering the lack of head‐to‐head comparative studies, this meta‐analysis aims to investigate the differences in efficacy between adding and not adding concurrent ICIs to CRT ...
Xu Tong +4 more
wiley +1 more source
ABSTRACT Background Neurotoxicity is a rare, often dose‐limiting adverse effect of methotrexate (MTX) therapy that disproportionally affects Latino children. Factors contributing to the observed disparity are not well understood. This study leveraged admixture mapping to identify genetic regions associated with MTX‐related neurotoxicity susceptibility ...
Rachel D. Harris +24 more
wiley +1 more source
Experimentail studies on the prevention of myelosuppression during cancer chemotherapy Part I : Accelerated recovery from cyclophosphamide induced myelosuppression by administration of Bestatin, 3-(R)-amino-2-(S)-hydroxy-4-phenylbutanoyl-(S)-leucine, in mice [PDF]
The hemopoietic potential of Bestatin, a new immunomodulator prepared from the culture medium of Streptomyces olivoreticuli, was studied concerning its effects on the recovery from cyclophosphamide(CPA)-induced myelosuppression and on autologous CFUs in ...
Uchida, Kozaburo
core
Precision medicine offers the opportunity to improve the benefit–risk profile of new therapies by prospectively identifying patients most likely to respond or least likely to experience harm; however, its systematic integration into drug development remains inconsistent outside oncology.
Ingrid Holst‐Laubjerg +1 more
wiley +1 more source

